+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product; By Distribution Channel; By Regions; Segment Forecast, 2020-2027

  • ID: 5261878
  • Report
  • December 2020
  • Region: Global
  • 104 pages
  • Polaris Market Research

FEATURED COMPANIES

  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Corbus Pharmaceuticals
  • Insys Therapeutics Inc.
  • Kao Corporation
  • Pfizer
The global cannabis pharmaceuticals market is expected to reach USD 5.72 billion by 2027, according to the study.

The report “Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet and Sativex); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Regions; Segment Forecast, 2020-2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals. Blockchain technology in the pharmaceutical industry could be used to maintain strain purity and product formulations to have effective treatment for the therapeutic cause and will also enable us to capture dosage data for future considerations, thus technology could also play important role in shaping the market future of the cannabis pharmaceuticals industry.

The global market for cannabis pharmaceuticals is fragmented based on product, distribution channel, and region. In terms of product, the market is segmented into Epidiolex, Marinol, Cesamet, and Sativex. Based on distribution channel, the cannabis pharmaceuticals industry is further bifurcated into hospital, online, and retail pharmacies.

Segment Highlights
  • Sativex segment accounted for the largest revenue share in 2019 owing to the growing usage of drug for the muscle spasticity. In addition, growing demand for plant-based pharmaceuticals is expected to drive market demand for cannabis pharmaceuticals.
  • Based on distribution channel, the hospitals pharmacies segment is projected to account for a significant share by 2027. The high share is attributed to the fact that most of the physicians recommend medicines from in-house pharmacy stores driving the cannabis medicines market growth.
  • Europe accounted for the largest share in 2019 in terms of revenue on account of the increasing demand for plant-based medicines and the increasing awareness pertaining to the medicinal benefits associated cannabis.
List of Key Players
  • GW Pharmaceuticals
  • Valeant Pharmaceuticals
  • Insys Therapeutics, Inc.
  • Corbus Pharmaceuticals
  • Teva Pharmaceutical
  • Avicanna
  • Solvay Pharmaceuticals
  • Cannabics Pharmaceuticals
  • Others
The analyst has segmented the cannabis pharmaceuticals market report on the basis of product, distribution channel, and region.

Cannabis Pharmaceuticals, Product Outlook (Revenue-USD Million, 2016-2027)
  • Sativex
  • Marinol
  • Cesamet
  • Epidiolex
Cannabis Pharmaceuticals, Distribution Channel Outlook (Revenue-USD Million, 2016-2027)
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Cannabis Pharmaceuticals, Regional Outlook (Revenue-USD Million, 2016-2027)
  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Bristol-Myers Squibb
  • Corbus Pharmaceuticals
  • Insys Therapeutics Inc.
  • Kao Corporation
  • Pfizer
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary
2.1. Market Highlights

3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources

4. Cannabis Pharmaceuticals Market Insights
4.1. Cannabis Pharmaceuticals - Industry snapshot
4.2. Cannabis Pharmaceuticals Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increased use in different therapeutic areas
4.2.1.2. Increased support in the form of clinical evidence
4.2.2. Restraints and Challenges
4.2.2.1. Shelf life of cannabidiol and cross reactions
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Cannabis Pharmaceuticals Market Industry trends

5. Cannabis Pharmaceuticals Market Assessment by Product
5.1. Key Findings
5.2. Introduction
5.2.1. Global Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
5.3. Sativex
5.3.1. Global Cannabis Pharmaceuticals Market, by Sativex, by Region, 2016-2027 (USD Million)
5.4. Epidiolex
5.4.1. Global Cannabis Pharmaceuticals Market, by Epidiolex, by Region, 2016-2027 (USD Million)
5.5. Marinol
5.5.1. Global Cannabis Pharmaceuticals Market, by Marinol, by Region, 2016-2027 (USD Million)
5.6. Cesamet
5.6.1. Global Cannabis Pharmaceuticals Market, by Cesamet, by Region, 2016-2027 (USD Million)

6. Global Cannabis Pharmaceuticals Market, by Distribution Channel
6.1. Key Findings
6.2. Introduction
6.2.1. Global Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Global Cannabis Pharmaceuticals Market, by Hospital Pharmacies, By Region, 2016-2027 (USD Million)
6.4. Online Pharmacies
6.4.1. Global Cannabis Pharmaceuticals Market, by Online Pharmacies, by Region, 2016-2027 (USD Million)
6.5. Retail Pharmacies
6.5.1. Global Cannabis Pharmaceuticals Market, by Retail Pharmacies, by Region, 2016-2027 (USD Million)

7. Cannabis Pharmaceuticals Market Assessment by Geography
7.1. Key findings
7.2. Introduction
7.2.1. Cannabis Pharmaceuticals Market Assessment, By Geography, 2016-2027 (USD Million)
7.3. Cannabis Pharmaceuticals Market - North America
7.3.1. North America: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.3.2. North America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.3.3. Cannabis Pharmaceuticals Market - U.S.
7.3.3.1. U.S.: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.3.3.2. U.S.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.3.4. Cannabis Pharmaceuticals Market - Canada
7.3.4.1. Canada: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.3.4.2. Canada.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4. Cannabis Pharmaceuticals Market - Europe
7.4.1. Europe: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.2. Europe: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.3. Cannabis Pharmaceuticals Market - UK
7.4.3.1. UK: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.3.2. UK: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.4. Cannabis Pharmaceuticals Market - France
7.4.4.1. France: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.4.2. France: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.5. Cannabis Pharmaceuticals Market - Germany
7.4.5.1. Germany: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.5.2. Germany: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.6. Cannabis Pharmaceuticals Market - Italy
7.4.6.1. Italy: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.6.2. Italy: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.7. Cannabis Pharmaceuticals Market - Spain
7.4.7.1. Spain: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.7.2. Spain: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.8. Cannabis Pharmaceuticals Market - Netherlands
7.4.8.1. Netherlands: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.8.2. Netherlands: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.4.9. Cannabis Pharmaceuticals Market - Austria
7.4.9.1. Austria: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.4.9.2. Austria: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5. Cannabis Pharmaceuticals Market - Asia-Pacific
7.5.1. Asia Pacific: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.2. Asia Pacific: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.3. Cannabis Pharmaceuticals Market - China
7.5.3.1. China: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.3.2. China: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.4. Cannabis Pharmaceuticals Market - India
7.5.4.1. India: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.4.2. India.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.5. Cannabis Pharmaceuticals Market - Malaysia
7.5.5.1. Malaysia: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.5.2. Malaysia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.6. Cannabis Pharmaceuticals Market - Japan
7.5.6.1. Japan: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.6.2. Japan: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.7. Cannabis Pharmaceuticals Market - Indonesia
7.5.7.1. Indonesia: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.7.2. Indonesia: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.5.8. Cannabis Pharmaceuticals Market - South Korea
7.5.8.1. South Korea: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.5.8.2. South Korea.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.6. Cannabis Pharmaceuticals Market - Middle East & Africa
7.6.1. Middle East & Africa: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.6.2. Middle East & Africa.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.6.3. Cannabis Pharmaceuticals Market - Saudi Arabia
7.6.3.1. Saudi Arabia: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.6.3.2. Saudi Arabia.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.6.4. Cannabis Pharmaceuticals Market - UAE
7.6.4.1. UAE: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.6.4.2. UAE: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.6.5. Cannabis Pharmaceuticals Market - Israel
7.6.5.1. Israel: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.6.5.2. Israel: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.6.6. Cannabis Pharmaceuticals Market - South Africa
7.6.6.1. South Africa: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.6.6.2. South Africa: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.7. Cannabis Pharmaceuticals Market - Latin America
7.7.1. Latin America: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.7.2. Latin America: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.7.3. Cannabis Pharmaceuticals Market - Mexico
7.7.3.1. Mexico: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.7.3.2. Mexico.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.7.4. Cannabis Pharmaceuticals Market - Brazil
7.7.4.1. Brazil: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.7.4.2. Brazil.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)
7.7.5. Cannabis Pharmaceuticals Market - Argentina
7.7.5.1. Argentina: Cannabis Pharmaceuticals Market, By Product, 2016-2027 (USD Million)
7.7.5.2. Argentina.: Cannabis Pharmaceuticals Market, By Distribution Channel, 2016-2027 (USD Million)

8. Competitive Landscape
8.1. Expansion and Acquisition Analysis
8.1.1. Expansion
8.1.2. Acquisition
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles
9.1. GW Pharmaceuticals
9.1.1. Company Overview
9.1.2. Financial Performance
9.1.3. Product Benchmarking
9.1.4. Recent Developments
9.2. Valeant Pharmaceuticals
9.2.1. Company Overview
9.2.2. Financial Performance
9.2.3. Product Benchmarking
9.2.4. Recent Developments
9.3. Insys Therapeutics, Inc.
9.3.1. Company Overview
9.3.2. Financial Performance
9.3.3. Product Benchmarking
9.3.4. Recent Developments
9.4. Corbus Pharmaceuticals
9.4.1. Company Overview
9.4.2. Financial Performance
9.4.3. Product Benchmarking
9.4.4. Recent Developments
9.5. Teva Pharmaceutical
9.5.1. Company Overview
9.5.2. Financial Performance
9.5.3. Product Benchmarking
9.5.4. Recent Developments
9.6. Avicanna
9.6.1. Company Overview
9.6.2. Financial Performance
9.6.3. Product Benchmarking
9.6.4. Recent Developments
9.7. Solvay Pharmaceuticals
9.7.1. Company Overview
9.7.2. Financial Performance
9.7.3. Product Benchmarking
9.7.4. Recent Developments
9.8. Sprint Corporation
9.8.1. Company Overview
9.8.2. Financial Performance
9.8.3. Product Benchmarking
9.8.4. Recent Developments
9.9. Cannabics Pharmaceuticals
9.9.1. Company Overview
9.9.2. Financial Performance
9.9.3. Product Benchmarking
9.9.4. Recent Developments
9.10. Kao Corporation
9.10.1. Company Overview
9.10.2. Financial Performance
9.10.3. Product Benchmarking
9.10.4. Recent Developments
Note: Product cover images may vary from those shown
  • GW Pharmaceuticals
  • AbbVie Inc.
  • Valeant Pharmaceuticals
  • Insys Therapeutics Inc.
  • Corbus Pharmaceuticals
  • Teva Pharmaceutical
  • Johnson & Johnson
  • Avicanna
  • Solvay Pharmaceuticals
  • Cannabics Pharmaceuticals
  • Portola Pharmaceuticals
  • Kao Corporation
  • Ogeda S.A.
  • Pfizer
  • Bristol-Myers Squibb
Note: Product cover images may vary from those shown
Adroll
adroll